Last week, our team attended ICONAN 2026, the Nanomedicine and Nanobiotechnology meeting held in Rome, where we presented our latest progress in the development of next-generation tumor-targeted nanoconjugates for targeted drug delivery in cancer. Presenting at ICONAN provided an excellent opportunity to discuss our approach with leading groups in the field and receive valuable feedback.
This morning, Informativos Telecinco featured our work at IR Sant Pau on a new class of protein-based nanoparticles engineered to home in on CXCR4+ tumor cells that drive metastasis while sparing healthy tissues. As Dr. Ugutz Unzueta explained during the segment, this selectivity aims to boost the effective dose at the tumor site and reduce
We are very happy to welcome Sude Bakirsoy to our laboratory this month! Sude is a final-year Bioengineering student at the Izmir Institute of Technology (Turkey), and she has joined our group for a one-month internship. During her stay, she will be learning about recombinant protein production and exploring how these proteins can be used
We are proud to welcome Bruna Clarà, a talented high school student, to our research team at Institut de Recerca Sant Pau, following her recognition as the winner of Exporecerca Jove 2025. This prestigious science and innovation fair is organized by MAGMA, an association dedicated to promoting youth research and fostering scientific vocations among young
Nanoligent, the cancer nanomedicine spin-off developed at UAB and IR Sant Pau, devoted to advancing the protein-based nanomedicines developed at Ulab, has won the Santander X Award in the UAB Emprèn competition. This prestigious recognition highlights our innovative approach to targeting metastatic cancer stem cells using advanced protein nanodrugs. The award reinforces Nanoligent’s position as
Our former PhD student Héctor López-Laguna has received the Extraordinary Doctorate Award for his thesis entitled “Simple Biochemistry for Complex Protein-Based Materials.”This thesis presents a novel protein self-assembly technology based on divalent cations, and explores its biotechnological and biomedical applications. It was submitted in 2023 as part of the Biotechnology PhD program at the Autonomous
Dr. Ugutz Unzueta has joined the 3-days CIBER-BBN Nanomedicine Network meeting held in Zaragoza (Spain) to showcase the technological capabilities of our group and connect with other researchers within the Spanish nanomedicine network; looking forward to new collaborations and synergies.
Our predoctoral student, Ariana Rueda, has traveled to China for a 3-month internship at the laboratory of Professors Peng Chen and Xingyuan Fan, as part of her international PhD program. The Protein Chemical Biology and Bioorthogonal Chemistry Laboratory is located within the College of Chemistry and Molecular Engineering at Peking University in Beijing, China. During
Our PhD student Lourdes Arena participated as a volunteer in the organization of the RESI Europe conference, held in Barcelona on April 1st. This opportunity arose through ABSTEC (the Association of Biotechnologists of Catalonia), of which both Lourdes and several members of our ULAB laboratory are members. The Redefining Every Stage of Investment (RESI) Conference,
Our predoctoral researcher, Lourdes Ailen Arena, has been awarded the prestigious INPhINIT 2024 predoctoral fellowship by the “la Caixa” Foundation. The ceremony took place at the main auditorium of the CosmoCaixa Museum, with the presence of various authorities, including Emilia Jordi (Director of the “la Caixa” Educational and Scholarship Area), Àngel Font (Executive Director of
